Catalyst Wire Dossier Catalyst Wire Dossier

Relugolix with Estradiol and Norethindrone Acetate

· Myovant Sciences GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Relugolix with Estradiol and Norethindrone Acetate, covering 2024-06-25 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

See pricing